相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes
M. J. Steinhardt et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Progressive multifocal leukoencephalopathy treated with nivolumab
Ethan Hoang et al.
JOURNAL OF NEUROVIROLOGY (2019)
Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor
M. M. Thurnher et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2019)
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Irene Cortese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab
Sebastian Rauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab
Ondine Walter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
Clemens Kuepper et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Ineffective treatment of PML with pembrolizumab Exhausted memory T-cell subsets as a clue?
Marc Pawlitzki et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies
Jerome Hadjadj et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2019)
A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy
Nobuo Sanjo et al.
JOURNAL OF NEUROLOGY (2019)
Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy
Chloe Medrano et al.
EMERGING INFECTIOUS DISEASES (2019)
T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathy
Dejan Pavlovic et al.
IMMUNOBIOLOGY (2018)
The national incidence of PML in Sweden, 1988-2013
Ellen Iacobaeus et al.
NEUROLOGY (2018)
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy
Muharrem Muftuoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
Ifigeneia Tzannou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies
Eric M. L. Williamson et al.
NEUROTHERAPEUTICS (2017)
The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era Prevention and Management
Eamonn S. Molloy et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2017)
Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review
Elizabeth C. Neil et al.
BLOOD ADVANCES (2017)
Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature
Christa S. Zerbe et al.
CLINICAL INFECTIOUS DISEASES (2016)
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS)
Jan Bauer et al.
ACTA NEUROPATHOLOGICA (2015)
Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
J. Hodel et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT
Judith Feucht et al.
BLOOD (2015)
JC polyomavirus mutants escape antibody-mediated neutralization
Upasana Ray et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives
Dejan Pavlovic et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
Treating Progressive Multifocal Leukoencephalopathy With Interleukin 7 and Vaccination With JC Virus Capsid Protein VP1
Mireia Sospedra et al.
CLINICAL INFECTIOUS DISEASES (2014)
PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section
Joseph R. Berger et al.
NEUROLOGY (2013)
Progressive Multifocal Leukoencephalopathy in Transplant Recipients
Farrah J. Mateen et al.
ANNALS OF NEUROLOGY (2011)
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient
A. Balduzzi et al.
BONE MARROW TRANSPLANTATION (2011)
Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression
Sarah Gheuens et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
Chen S. Tan et al.
LANCET NEUROLOGY (2010)
Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study
Frederik Neess Engsig et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients
F. Ginevri et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders:: Impact of novel therapies
J García-Suárez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-Cell lines in seropositive healthy individuals and renal transplant recipients
P Comoli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
JC virus load in progressive multifocal leukoencephalopathy:: Analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions
D Garcia de Viedma et al.
CLINICAL INFECTIOUS DISEASES (2002)
分享论文
